Evaluation of Electronic Florbetapir (18F) Interpretation Training in Japanese Physicians

NCT02029547 · clinicaltrials.gov ↗

NA

Phase

WITHDRAWN

Status

INDUSTRY

Sponsor class

Conditions

Alzheimer's Disease

Interventions

DRUG: Florbetapir (18F)

Sponsor

Avid Radiopharmaceuticals